D.C

. Lun

g C

ance

r Con

fere

nce

201

9

For

mo

re in

fro

mat

ion

and

to re

gis

ter,

ple

ase

visi

tCE.M

edStarHea

lth.org

/Lung

Med

Star

Hea

lth

3007

Tild

en S

t., N

W, S

uite

3N

Was

hing

ton,

DC

2000

8

Continuing Education Credit Information Course Description

This one-day symposium will provide an update on recent clinical advances in lung cancer. We have seen high impact advances in all aspects of lung cancer management, from detection to diagnosis and treatment. This symposium will emphasize current best practices for busy clinicians who care for patients with lung cancer, across disciplines. High impact didactic talks will be delivered by national thought leaders and well-respected faculty in each field. There will be updates on CT screening and smoking cessation, proper use of liquid biopsy, interpretation of molecular testing results and review of modern bronchoscopic interventions. A section will be dedicated to optimizing multidisciplinary care for early stage and locally advanced lung cancer to include discussions on proton beam radiation, minimally invasive surgery and immunotherapy as well as an introduction to oligometastatic cancer and its proper management. Sessions with important updates on targeted therapy and immunotherapy will feature recognized experts in the field and there will be a debate over optimal management of metastatic, PD-L1 positive NSCLC. Attendees will have the opportunity to interact with faculty in frequent Q&A sessions and through a case-based format following each session with access to presentation materials for later review.

Learning Objectives

Physicians

• Explain the benefit of CT screening for lung cancer

• Discuss the current application of liquid biopsy (ctDNA analysis)

• Explain the role of multidisciplinary care for early-stage/locally advanced non-small cell lung cancer

• Discuss management options for patients with oligometastatic non-small cell lung cancer

• Discuss standard targeted agents in use for patients with driver-positive non-small cell lung cancer (including EGFR, ALK, ROS1, RET, NTRK, and MET)

• Describe the benefit of immunotherapy in the treatment of advanced small cell lung cancer

• Debate the controversies of immunotherapy alone or chemo-immunotherapy for PD-L1 positive non-small cell lung cancer

• Discuss management of immune-mediated toxicities Nurses

• Explain the benefit of CT screening for lung cancer

• Discuss the current application of liquid biopsy (ctDNA analysis)

• Explain the role of multidisciplinary care for early-stage/locally advanced non-small cell lung cancer

• Identify nursing strategies for early detection of immune-mediated toxicities

• Cite unique toxicities associated with targeted agents used in NSCLC

• Recognize commune immune related adverse events and factors that increase patient risk

Pharmacists

• Discuss standard targeted agents in use for patients with driver-positive non-small cell lung cancer

• Discuss the role of multidisciplinary care for locally advanced non-small cell lung cancer

• Describe the benefit of immunotherapy in the treatment of advanced small cell lung cancer

• Understand the pharmacologic management of immune-mediated adverse events based on current guidelines and evidence

Target Audience

This conference is intended for pulmonologists, medical and radiation oncologists, pathologists, radiologists, nuclear medicine physicians, interventional radiologists, thoracic surgeons, residents, fellows, medical students, physician assistants, nurse practitioners, nurses, pharmacists, allied health professionals, and other members of the healthcare team interested in the diagnosis and treatment of lung cancer.

CE Accreditation

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American

Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 6.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

PharmacistsThis curriculum has been approved for 6.5 contact hours by MedStar Health. MedStar Health is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The Universal Activity Number for this program is JA4008151-0000-19-026-L01- P. This learning activity is knowledge-based.

D.C. Lung Cancer Conference

November 16, 2019Washington Marriott Wardman Park | Washington, D.C.

Course DirectorsStephen V. Liu, MDMedStar Georgetown University HospitalWashington, D.C.

Chul Kim, MD, MPHMedStar Georgetown University HospitalMedStar Washington Hospital CenterWashington, D.C.

2019

#DCLUNG19Nove

mbe

r 16,

201

9 |

Was

hing

ton

Mar

riott

War

dman

Par

k | W

ashi

ngto

n, D

.C.

Course DirectorsStephen V. Liu, MDDirector, Thoracic Medical OncologyDirector, Phase I Developmental TherapeuticsMedStar Georgetown University HospitalAssociate Professor, MedicineGeorgetown University Medical CenterWashington, D.C.

Chul Kim, MD, MPHThoracic Medical OncologistMedStar Georgetown University Hospital Assistant Professor, MedicineGeorgetown University Medical CenterWashington, D.C.

Agenda 8:00 a.m. Registration and Continental Breakfast

SESSION I: Diagnosing Lung Cancer in the Modern EraModerator: John F. Lazar, MD

9:10 a.m. Case Presentation Hira Latif, MD

9:20 a.m. The Current Status of CT Screening Eric D. Anderson, MD

9:40 a.m. The Evolving Role of Liquid Biopsy in Lung Cancer Benjamin P. Levy, MD

10:00 a.m. Advances in Peripheral Lung Access & Bronchoscopic Interventions Jessica S. Wang Memoli, MD

10:20 a.m. Panel Discussion

10:30 a.m. Break and Visit the Exhibits

SESSION II: Multidisciplinary Management of Locally Advanced Lung CancerModerator: Puja G. Khaitan, MD

10:50 a.m. Case Presentation Monica Peravali, MD

11:00 a.m. Proton Beam Radiation Therapy in Lung Cancer Jonathan W. Lischalk, MD

11:20 a.m. Surgical Management of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Marc Margolis, MD

11:40 a.m. Immunotherapy in Resectable or Locally Advanced NSCLC Chul Kim, MD, MPH

12:00 p.m. Managing Oligometastatic NSCLC Joshua Bauml, MD

12:20 p.m. Panel Discussion

12:30 p.m. Lunch and Visit the Exhibits

SESSION III: Updates on Targeted Therapy in Lung CancerModerator: Chul Kim, MD, MPH

1:30 p.m. Case Presentation Sushma R. Jonna, MD

1:40 p.m. Sequencing Therapies in ALK Positive NSCLC Jessica J. Lin, MD

2:00 p.m. Optimizing Care in EGFR Positive NSCLC Irina Veytsman, MD

2:20 p.m. Evolving Targets Beyond EGFR and ALK Alexander E. Drilon, MD

2:40 p.m. Panel Discussion

SESSION IV: Advances in Immunotherapy for Lung CancerModerator: Stephen V. Liu, MD

2:50 p.m. Case Presentation Michael T. Serzan, MD

3:00 p.m. Immunotherapy for Small Cell Lung Cancer Stephen V. Liu, MD

3:20 p.m. Debate: Managing Advanced PDL1 Positive NSCLC − Monotherapy Balazs Halmos, MD

3:40 p.m. Debate: Managing Advanced PDL1 Positive NSCLC − Chemo- Immunotherapy Hossein Borghaei, DO, MS

4:00 p.m. Nursing Perspectives in the Mangement of Immunotherapy Simona Armanca, PharmD, BCOP; Eunice A. Ochuonyo MSN, FNP-C

4:20 p.m. Panel Discussion and Challenging Cases

4:45 p.m. Closing Remarks

Registration Information

Registration Fees:

Physician $175

Resident or Fellow $100

Physician Assistant $100

Nurse Practitioner $100

Nurse $100

Pharmacist $100

Allied Health Professional $100

Venue InformationWashington Marriott Wardman Park2660 Woodley Road, NWWashington, D.C. 20008202-328-2000https://wardmanparkmarriott.com

A block of rooms has been reserved for attendees at the hotel at the discounted rate of $139 per night (exclusive of taxes and fees). Reserve your room by October 25 to take advantage of this rate. Reservations can be made by calling 1-877-212-5752 or online at http://bit.ly/LungWP

Special Assistance

MedStar Health wishes to ensure that no individual with a disability is excluded, denied services, segregated or otherwise treated differently from other individuals because of the absence of auxiliary aids or services identified in the Americans with Disabilities Act. Please contact 202-735-3104 to notify us of your needs.

FacultyEric D. Anderson, MDDirector, Interventional PulmonologyMedStar Georgetown University HospitalProfessor, Clinical MedicineGeorgetown University Medical CenterWashington, D.C.

Simona L. Armanca, PharmD, BCOPClinical Pharmacy SpecialistMedStar Georgetown University HospitalWashington, D.C.

Joshua Bauml, MDAssistant Professor, MedicinePerelman School of Medicine at the University of PennsylvaniaPhiladelphia, PA

Hossein Borghaei, DO, MSChief, Thoracic Medical OncologyProfessor, Hematology and OncologyThe Gloria and Edmund M. Dunn Chair in Thoracic OncologyFox Chase Cancer CenterPhiladelphia, PA

Alexander E. Drilon, MDClinical Director, Early Drug Development ServiceAssociate Attending Physician Thoracic Oncology ServiceMemorial Sloan Kettering Cancer CenterNew York, NY

Balazs Halmos, MDDirector, Thoracic/Head and Neck OncologyMontefiore Medical CenterProfessor, MedicineAlbert Einstein College of MedicineBronx, NY

Sushma Jonna, MDClinical FellowHematology/OncologyGeorgetown Lombardi Comprehensive Cancer CenterWashington, D.C.

Puja Gaur Khaitan, MDDirector, Esophageal SurgeryMedStar Washington Hospital CenterAssociate Professor, Division of Thoracic SurgeryGeorgetown University Medical Center Washington, D.C.

Hira Latif, MDChief Fellow, Hematology- OncologyMedStar Washington Hospital CenterWashington, D.C.

John F. Lazar, MDDirector, Thoracic Robotic SurgeryThoracic SurgeonMedStar Washington Hospital CenterAssistant Professor, MedicineGeorgetown University Medical CenterWashington, D.C. Benjamin P. Levy, MDClinical Director, Medical OncologyThoracic Medical OncologistJohns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial HospitalAssociate Professor, OncologyJohns Hopkins University School of MedicineWashington, D.C.

Jessica J. Lin, MDMedical Oncologist/Hematologist Massachusetts General HospitalInstructor, MedicineHarvard Medical SchoolBoston, MA

Jonathan W. Lischalk, MDRadiation OncologistMedStar Georgetown University HospitalAssistant Professor, MedicineGeorgetown University Medical CenterWashington, D.C.

Marc Margolis, MDThoracic SurgeonMedStar Georgetown University HospitalWashington, D.C.

Eunice A. Ochuonyo MSN, FNP-CNurse Practitioner MedStar Georgetown University HospitalWashington, D.C.

Monica Peravali, MDMedical Oncologist/Hematologist MedStar Washington Hospital Center Washington, D.C.

Michael T. Serzan, MDClinical FellowHematology/OncologyMedStar Georgetown University HospitalWashington, D.C.

Irina G. Veytsman, MDSection Director, Hematology/OncologyMedical Oncologist/Hematologist MedStar Washington Hospital CenterWashington, D.C.

Jessica S. Wang Memoli, MDPulmonary, Critical Care, and Respiratory ServicesMedStar Washington Hospital CenterWashington, D.C.

Online Registration Preferred

Please visit our secure website at CE.MedStarHealth.org/Lung for updated program and registration information. We are unable to accept registrations or cancellations by telephone. If you wish to pay your registration fee by check, please download and print a registration form and mail it to the address on the registration form with your check.

All registrations will be confirmed by email only. Please use an email address that you check regularly. If you have questions regarding registration or do not receive an email confirmation of your registration within 1-2 business days, please contact us at MedStarCME@gmail.com or 202-735-3104. Cancellation Policy

Cancellations made in writing by October 16, 2019 will be subject to a 50% penalty. No refunds will be given after this date. Cancellations will not be accepted by telephone. In the unlikely event that the course is canceled, MedStar Health will refund the registration fee, but is not responsible for any travel costs.

Please call 202-735-3104 or email MedStarCME@gmail.com if you have any questions or need any additional information.